This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Health, product development and other information on cannabis-derived cannabinoids like cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol (CBN) and more, including cannabis oil concentrates, isolates and distillates, as well as cannabutter, for developing legal recreational and medical cannabis edibles and beverages.
Industry members have been calling on the UK government to develop a framework for regulating and selling CBD products since it had vowed to do so in 2021.
ONE HEMP unites CBD industry stakeholders to work toward more stringent regulatory standards, including independent third-party testing and accurate labeling.
A group of cannabis and CBD companies is calling on the UK’s Home Office to establish a legal framework for the sale of CBD products more than two years after it committed to regulating around the cannabinoid.
The FDA said it does not intend to pursue rulemaking around the inclusion of CBD in dietary supplements or conventional food, but it is prepared to work with Congress on the issue.
Real Isolates LLC has been issued a patent by the United States Patent and Trademark Office for a method used to extract cannabinoids and other compounds from cannabis smoke.
Caliper Foods recently completed a clinical research study in partnership with Colorado State University that showed that formulation design makes a significant difference in CBD pharmacokinetics.